When most people first learn about the allegations against Fresenius Medical Care, their reaction is disbelief. How could the largest operator of dialysis centers in the United States push a product that causes heart attacks and sudden death in hundreds of patients?
The allegations, perhaps, sound too extreme. But the story is compelling. By ignoring — and perhaps actively suppressing — biochemical and clinical evidence the dangers of its dialysis product, GranuFlo, Fresenius may have caused the deaths of hundreds of people and torn apart thousands of families. Even after admitting to “troubling findings” about GranuFlo that needed to be “addressed urgently,” the company did nothing.
How could this have happened? How did the American consumer protection edifice fail so catastrophically? And what can be done to repair the harm done?
In today’s post and several to follow, we will reveal the remarkable and disturbing story of the GranuFlo debacle. This series — which is also available in eBook form (downloadable below) — is designed to help the following people:
1. Dialysis patients (and friends and family of patients) who got hurt while on GranuFlo.
2. Journalists and citizens concerned about how to hold drug manufacturers — and the medical industry as a whole — accountable for negligence and carelessness.
Unfortunately, Fresenius’s bullheaded promotion of a dangerous drug is likely not an anomaly. Could there be a more general pathology at work that is derailing our collective ability to regulate medical devices and products? If so, what is at the root of that pathology? What can be done in the future to stop or at least minimize similar disasters?
We will attempt to answer these big questions, as well as to provide tools and resources for patients and their families, so that they can understand the current state of GranuFlo litigation and become more empowered advocates in the system.
For a free consultation about your GranuFlo case, please call Davis & Crump at 800-277-0300 or email us at info@daviscrump.com.
